Cohance Lifesciences Ltd Stock Fundamentals

Cohance Lifesciences Ltd Share Price
Detail Overview
Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹457.60
-1.00(-0.22%)
As on 16 Nov 2026 at 15:57
As of 16 Nov 2026 at 15:57, Cohance Lifesciences Ltd is trading at ₹457.60. The 52-week range stands at ₹266.70–₹676.55, with a market cap of ₹17.55 thousand crore. At a P/E of 159.22 and a dividend yield of 0.00%, it is a mid-cap stock in the Pharmaceuticals sector.
Market Cap
₹17.55K Cr
PE Ratio
159.22
ROCE
3.44%

Cohance Lifesciences Ltd Fundamentals

Market Cap₹17.55K Cr
ROE2.44%
P/E Ratio (TTM)159.22
EPS (TTM)₹2.88
P/B Ratio3.89
Dividend Yield0.00%
Industry P/E91.00
Book Value₹117.86
Debt to Equity0.04
Face Value₹1

Frequently asked questions

The Cohance Lifesciences Ltd revenue for the latest reported period is ₹2,031 crore, compared with ₹2,504 crore in the corresponding previous period.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now